Search

Your search keyword '"Histoplasma growth & development"' showing total 80 results

Search Constraints

Start Over You searched for: Descriptor "Histoplasma growth & development" Remove constraint Descriptor: "Histoplasma growth & development" Topic histoplasmosis Remove constraint Topic: histoplasmosis
80 results on '"Histoplasma growth & development"'

Search Results

1. Bone Marrow Culture Yield for the Diagnosis of Opportunistic Diseases in Patients with AIDS and Disseminated Kaposi Sarcoma.

2. A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil.

3. Differentiation of the fungus Histoplasma capsulatum into a pathogen of phagocytes.

4. An unusual cause of fever in a patient with common variable immunodeficiency.

5. HcZrt2, a zinc responsive gene, is indispensable for the survival of Histoplasma capsulatum in vivo.

6. Macrophage cell death and transcriptional response are actively triggered by the fungal virulence factor Cbp1 during H. capsulatum infection.

7. Profile of cytokines in the lungs of BALB/c mice after intra-nasal infection with Histoplasma capsulatum mycelial propagules.

8. Usefulness of the murine model to study the immune response against Histoplasma capsulatum infection.

9. [Diagnosing a case of disseminated histoplasmosis with a blood smear].

10. How many have died from undiagnosed human immunodeficiency virus-associated histoplasmosis, a treatable disease? Time to act.

11. Rapid identification of Histoplasma capsulatum directly from cultures by multiplex PCR.

12. Rapid quantification of pathogenic fungi by Cellometer image-based cytometry.

13. [Pulmonary nodules upon return from Costa Rica].

14. Histoplasma capsulatum prosthetic valve endocarditis with negative fungal blood cultures and negative histoplasma antigen assay in an immunocompetent patient.

15. [Histoplasmosis outbreak in Morón, Buenos Aires Province, Argentina].

16. A histoplasma capsulatum-specific IgG1 isotype monoclonal antibody, H1C, to a 70-kilodalton cell surface protein is not protective in murine histoplasmosis.

17. Validation and clinical application of a molecular method for identification of Histoplasma capsulatum in human specimens in Colombia, South America.

18. Equine histoplasmosis: treatment trial in cart horses in Central Ethiopia.

19. Histoplasma capsulatum pathogenesis: making a lifestyle switch.

20. A monoclonal antibody to Histoplasma capsulatum alters the intracellular fate of the fungus in murine macrophages.

21. The genetic basis of variation in susceptibility to infection with Histoplasma capsulatum in the mouse.

22. [Histoplasmosis with cutaneous manifestations in HIV/AIDS patients].

23. [Differential diagnosis of visceral leishmaniasis, progressive disseminated histoplasmosis and penicilliosis marneffei].

24. Preliminary trial on the reproducibility of epizootic lymphangitis through experimental infection of two horses.

25. [A case of disseminated histoplasmosis misdiagnosed as visceral leishmaniasis].

26. [Dimorphism and pathogenesis of Histoplasma capsulatum].

27. Equine histoplasmosis presenting as a tumor in the abdominal cavity.

28. B cells and CD4-CD8- T cells are key regulators of the severity of reactivation histoplasmosis.

29. Unusual orofacial manifestations of histoplasmosis in renal transplanted patient.

30. Histofarcin test for the diagnosis of epizootic lymphangitis in Ethiopia: development, optimisation, and validation in the field.

31. A 36-year-old woman with a unilateral breast mass. Necrotizing granulomatous mastitis secondary to budding yeast forms morphologically consistent with Histoplasma capsulatum.

32. A 43-year-old woman with acquired immunodeficiency syndrome and fever of undetermined origin. Disseminated histoplasmosis.

33. Necrotizing pneumonia with a questionable lung mass in a 59-year-old man.

34. Histoplasmosis associated with exploring a bat-inhabited cave in Costa Rica, 1998-1999.

35. Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis.

36. Protective and memory immunity to Histoplasma capsulatum in the absence of IL-10.

37. Knocking on the right door and making a comfortable home: Histoplasma capsulatum intracellular pathogenesis.

38. Molecular mycology: a genetic toolbox for Histoplasma capsulatum.

39. Intracellular parasitism by Histoplasma capsulatum: fungal virulence and calcium dependence.

40. Molecular epidemiology, pathogenesis, and genetics of the dimorphic fungus Histoplasma capsulatum.

41. Complex requirements for nascent and memory immunity in pulmonary histoplasmosis.

42. Antihistoplasmal in vitro and in vivo effect of Lys-Nva-FMDP.

43. Duration of fungal culture incubation in an area endemic for Histoplasma capsulatum.

44. Activation of human macrophage fungistatic activity against Histoplasma capsulatum upon adherence to type 1 collagen matrices.

45. A natural focus of Histoplasma capsulatum var. duboisii is a bat cave.

46. Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis.

47. Aberrant Histoplasma capsulatum. Confirmation of identity by a chemiluminescence-labeled DNA probe.

48. Diagnosis of systemic histoplasmosis in AIDS patients.

49. Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts.

50. Recovery of Histoplasma capsulatum from blood in a commercial radiometric Mycobacterium medium.

Catalog

Books, media, physical & digital resources